Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trialVivianne C. G. Tjan‐Heijnen, R. Vree, Irene E.G. van Hellemond et al.|The Lancet Oncology|2017Cited by 158
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort studyKarlijn de Joode, C. R. van Rooijen, Pim Mutsaers et al.|European Journal of Cancer|2020Cited by 78
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 ConsortiumKarlijn de Joode, Susan C. van ‘t Westeinde, Jolien Tol et al.|European Journal of Cancer|2021Cited by 9